Consistent with activation of the type I IFN pathway, we found that MUC1 significantly associates with (i) STAT2 and IRF9 expression in TNBC tumors (Figure 1C) and (ii) IRF9 in a scRNA-seq dataset from TNBC tumor cells (Figure 1D). Here, IRF9 is linked to neoplasm.